KT621-AD-102 Enrolling

Adults Eczema Study (3 Months)


Treatment: Oral Age: 18+ Years


Who Can Participate?

Adults aged 18 to 55 with moderate to severe eczema (atopic dermatitis) may participate.

Inclusion Criteria

  • have a diagnosis of AD, with duration of AD of at least 1 year
  • have AD not adequately controlled with other topical prescription therapies or when those therapies are not advisable
  • the eczema covering your body is equal to about 10 or more of your palm prints (about 10% of your body)

Participant Information

  • Participate and receive study treatment at no cost
  • Regular visits with study doctors who specialise in treating eczema (5 visits)
  • Will receive either an investigative oral treatment (study drug) or a placebo
  • Reimbursement for study-related expenses may be provided

How Long Will The Study Last?

  • 11 weeks

Participating Locations

COUNTRY
country-icon
United States

Participating Experts

No Doctors Found

You May Also Be Interested In

Similar Trials

No Similar Trials Found

The following information is from ClinicalTrials.gov

Last Update Posted: May 08, 2025

Official Title

A Phase 1b Open-label, Multicenter, Single-arm Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered KT-621 in Adult Participants With Moderate to Severe Atopic Dermatitis

ClinicalTrials.gov ID

NCT06945458

Sponsor

Kymera Therapeutics, Inc.

Study Description

  • Brief Summary:

    This is a study to evaluate safety, tolerability, pharmacokinetics, pharmacodynamics, and clinical activity of orally administered KT-621 in adult male and female patients with moderate to severe atopic dermatitis (AD).

  • Condition or Disease:

    Atopic Dermatitis

  • Intervention/Treatment:

    Drug: KT-621
  • Phase:

    PHASE 1

  • Ages Eligible for Study:

    18 Years and 55 Years (ADULT)

  • Sexes Eligible for Study:

    ALL


Terms and Conditions – ClinicalTrials.gov
Purpose of ClinicalTrials.gov Database. The U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine, has developed ClinicalTrials.gov to provide patients, family members, and members of the public current information about clinical research studies.



about-icon

Learn More About

ECZEMA - ATOPIC DERMATITIS

Learn More
2025 all rights reserved Probity Medical Research Inc
find a trial
General Registration

Can’t find a trial? Not sure which trial to choose? Complete a general registration and we’ll contact you with suitable trials.

Register
filter trials
Skip to content